Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller

Journal of Surgical Research

Volumn 185, Issue 1, 2013, Pages 250-254

  Tao, Hiroyuki ^a   Hayashi, Tatsuro ^a   Sano, Fumiho ^a   Takahagi, Akihiro ^a   Tanaka, Toshiki ^a   Matsuda, Eisuke ^a   Okabe, Kazunori ^a  

^a NATIONAL SANYO HOSPITAL   (Japan)

Author keywords

Lymphovascular invasion; Non small cell lung cancer; Prognostic factor; Recurrence; Visceral pleural invasion

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PLEURA; PLEURA METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RISK FACTOR; TREATMENT OUTCOME; TUMOR INVASION; UNIVARIATE ANALYSIS;

LYMPHOVASCULAR INVASION; NON-SMALL-CELL LUNG CANCER; PROGNOSTIC FACTOR; RECURRENCE; VISCERAL PLEURAL INVASION;

AGED; BLOOD VESSELS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC SYSTEM; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PLEURA; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR BURDEN;

EID: 84886716544     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.05.104     Document Type: Article

References (27)

1. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours J Thorac Oncol 2 2007 706
2. R. Rami-Porta, D. Ball, and J. Crowley The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer J Thorac Oncol 2 2007 593
3. C. Hamada, F. Tanaka, and M. Ohta Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer J Clin Oncol 23 2005 4999
4. C. Hamada, M. Tsuboi, and M. Ohta Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials J Thorac Oncol 4 2009 1511
5. W.D. Travis, E. Brambilla, and R. Rami-Porta Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer J Thorac Oncol 3 2008 1384
6. N.S. Goldstein, A. Mani, G. Chmielewski, R. Welsh, and S. Pursel Prognostic factors in T1 NO MO adenocarcinomas and bronchioloalveolar carcinomas of the lung Am J Clin Pathol 112 1999 391
7. T. Tsuchiya, S. Akamine, and M. Muraoka Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy Lung Cancer 56 2007 341
8. F. Shoji, A. Haro, and T. Yoshida Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer Ann Thorac Surg 89 2010 864
9. S. Shiono, M. Abiko, and T. Sato Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers J Thorac Oncol 6 2011 43
10. H. Igai, N. Matsuura, and S. Tarumi Prognostic factors in patients after lobectomy for p-T1aN0M0 adenocarcinoma Eur J Cardiothorac Surg 41 2012 603
11. K.A. Higgins, J.P. Chino, and N. Ready Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy J Thorac Oncol 7 2012 1141
12. M. Tsuboi, T. Ohira, and H. Saji The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer Ann Thorac Cardiovasc Surg 13 2007 73
13. W.D. Travis, E. Brambilla, and H.K. Mullar-Hermelink World Health Organization classification of tumors: pathology and genetics of tumours of the lung, pleura, thymus and heart 2004 IARC Press Lyon
14. J.J. Hung, W.J. Jeng, W.H. Hsu, T.Y. Chou, B.S. Huang, and Y.C. Wu Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer J Thorac Oncol 7 2012 1115
15. The Japan Lung Cancer Society General rule for clinical and pathological record of lung cancer [in Japanese] 6th ed. 2003 Kanehara Tokyo
16. J. Yoshida, K. Nagai, and H. Asamura Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database J Thorac Oncol 4 2009 959
17. T. Tsuchiya, S. Hashizume, and S. Akamine Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer Chest 132 2007 170
18. S.F. Schoppmann Lymphangiogenesis, inflammation and metastasis Anticancer Res 25 2005 4503
19. J. Wang, J. Chen, X. Chen, B. Wang, K. Li, and J. Bi Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis PloS One 6 2011 e28844
20. R. Maeda, J. Yoshida, and G. Ishii Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension Chest 138 2010 357
21. R. Maeda, J. Yoshida, G. Ishii, T. Hishida, M. Nishimura, and K. Nagai Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification Chest 139 2011 855
22. J.P. Pignon, H. Tribodet, and G.V. Scagliotti Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552
23. J.Y. Douillard, H. Tribodet, and D. Aubert Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation J Thorac Oncol 5 2010 220
24. J.M. Brechot, S. Chevret, and M.C. Charpentier Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: correlation with TNM stage and disease free and overall survival Cancer 78 1996 2111
25. Y. Ichinose, T. Yano, H. Asoh, H. Yokoyama, I. Yoshino, and Y. Katsuda Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer: an analysis in each pathologic stage J Thorac Cardiovasc Surg 110 1995 601
26. K. Suzuki, K. Nagai, and J. Yoshida Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma: a comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses Cancer 86 1999 1976
27. K. Miyoshi, S. Moriyama, T. Kunitomo, and S. Nawa Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer J Thorac Cardiovasc Surg 137 2009 429